Welcome to the Institute of Clinical Research

Welcome to the Institute of Clinical Research

About Us

The Institute of Clinical Research (ICR) is the probably the oldest independent membership-led professional body for global clinical researchers.  

For over 40 years, The Institute of Clinical Research (ICR) has provided high quality training, networking and support to the clinical research community.  For many Members the Institute has been part of their life throughout their working careers, many have been with the Institute since its first incarnation as the ACRPI.

It is the membership that makes the Institute.

How does it all work ?

The Institute of Clinical Research is you, the Membership governed by the Articles of Memorandum drawn up by the founding members.

The Board is made up of members who give their time freely to guide the future direction of the ICR.

The ICR Secretariat is the administrative arm of the Institute, its primary focus is to ensure that the wishes of the Board and Membership are carried out and to see to the day to day tasks that any membership organisation generates.


Our Mission

The ICR exists to support our members through all stages of their careers. We do this, in part, by:

  • Defining and refining standards for our profession
  • Providing a forum for discussion of key issues impacting clinical research
  • Promoting good relations with other healthcare related groups 
  • Providing opportunities for learning and development to enhance professional competence 
  • Enhancing public confidence and understanding of clinical research


Current News

Fungus-derived cancer killing drug by Oxford University shows promise

By ICR Secretariat / 14/10/2021 11:04 AM

A chemotherapy drug, NUC-7738, which is derived from a Himalayan fungus has been found to have 40 times greater potency in killing cancer cells than i…

Sanofi, GSK, Pfizer and Boehringer must face Zantac class-action lawsuits, court rules

By ICR Secretariat / 14/10/2021 11:03 AM

Even after the global Zantac recalls of 2019 and 2020 and the associated controversy, the courtroom saga over the medicine's risk is just getting star…

First subject given COVID-19 vaccine candidate in UK-based Scancell’s COVIDITY trial

By ICR Secretariat / 14/10/2021 11:00 AM

UK-based Scancell Holdings has announced that its first subject has been dosed in its COVIDITY clinical trial in South Africa. The trial is a partners…

ABPI: UK’s clinical research enduring slow recovery

By ICR Secretariat / 11/10/2021 11:51 AM

According to a report from the Association of the British Pharmaceutical Industry (ABPI), the UK is taking longer to recover from the COVID-19 pandemi…

Worrisome side effects lead Pfizer to narrow Duchenne gene therapy trial

By ICR Secretariat / 11/10/2021 11:49 AM

Pfizer plans to change the design of a closely watched late-stage trial of an experimental gene therapy for Duchenne muscular dystrophy after three pa…

UK at-home health startup raises £2 million in first round of funding

By ICR Secretariat / 11/10/2021 11:44 AM

Sanome, an early-stage biotech company based in London and Cambridge, has received support from health and biotech investors from the UK and Europe in…

Chinese drugmaker Clover says vaccine prevents COVID-19 in large trial

By ICR Secretariat / 30/09/2021 11:51 AM

  • Chinese drugmaker Clover Biopharmaceuticals said Wednesday its experimental coronavirus vaccine prevented COVID-19 in a large Phase 3 trial, reportin…

UK trial to evaluate existing drugs for secondary breast cancer

By ICR Secretariat / 30/09/2021 11:46 AM

A new UK-based clinical trial will evaluate existing cancer drugs as potential treatments for women living with metastatic breast cancer.

AstraZeneca strikes deal with university spinoff to turn RNA into drugs

By ICR Secretariat / 30/09/2021 11:45 AM

  • AstraZeneca is putting money into a recently launched university spinoff that aims to turn RNA into self-reproducing medicines, announcing Thursday a…

Keytruda made available on the NHS for certain oesophageal cancer patients

By ICR Secretariat / 23/09/2021 03:15 PM

The National Institute for Health and Care Excellence (NICE) has recommended MSD’s Keytruda (pembrolizumab) combined with chemotherapy for the first-l…

ESMO: With massive tumor progression edge, AstraZeneca-Daiichi's Enhertu shows Roche's Kadcyla who's the better breast cancer drug

By ICR Secretariat / 23/09/2021 03:14 PM

Pharma watchers have always suspected that AstraZeneca and Daiichi Sankyo’s Enhertu is a better HER2 therapy than Roche’s Kadcyla. But guessing is all…

NICE backs Opdivo for head and neck cancer

By ICR Secretariat / 23/09/2021 03:13 PM

The National Institute for Health and Care Excellence (NICE) has recommended Bristol Myers Squibb’s (BMS) immunotherapy Opdivo (nivolumab) for routine…

Novavax begins COVID-19, flu combination vaccine trial

By ICR Secretariat / 16/09/2021 10:32 AM

Novavax has launched a Phase I/II study evaluating a combination vaccine for the prevention of both COVID-19 and seasonal influenza, the US biotech co…

Covid: Vaccine protection still strong - Oxford jab creator

By ICR Secretariat / 16/09/2021 10:30 AM

The vaccines are still providing strong protection, a year on from the initial two doses, says the scientist who developed the Oxford-AZ vaccine.

AstraZeneca's COVID-19 shot joins the list of vaccines flagged for rare Guillain-Barre syndrome

By ICR Secretariat / 16/09/2021 10:29 AM

Two months after the FDA flagged Johnson & Johnson’s COVID-19 vaccine for the rare nerve disorder Guillain-Barre syndrome (GBS) Europe’s drug regu…

Events and Courses

ISO-14155:2011 - Clinical Investigation of Medical Devices for Human Subjects - Good Clinical Practice K28

Medical Devices have a fundamental role in saving lives by providing innovative healthcare solutions for the diagnosi...

Statistics for Non-Statisticians K35

Statistics is the art and science of summarising data.  Statistics play an essential role in all stages of clinical research from design throu...

Clinical Trial Administration - Beyond the Basics K36

Clinical Trial Administrators are at the heart of any project team...

Vendor Oversight in Clinical Trials K37

Vendor Oversight is currently a hot topic as sponsors and vendors aim to get to grips with what is really required.  You don’t want to outsource ...

Clinical Investigations for Medical Devices - Foundation K34

In this one day course we explore clinical investigations for medical devices.  We will review the latest legislation and its impact on determini...

Essentials of Clinical Trial Monitoring K38

This practical course defines the role of the clinical research monitor and explains the interaction with others in key roles as part of the clinical ...

Current Jobs